GB1170790A - Tetrahydro-Halo-Sulphamyl-Quinazolinones - Google Patents

Tetrahydro-Halo-Sulphamyl-Quinazolinones

Info

Publication number
GB1170790A
GB1170790A GB57788/66A GB5778866A GB1170790A GB 1170790 A GB1170790 A GB 1170790A GB 57788/66 A GB57788/66 A GB 57788/66A GB 5778866 A GB5778866 A GB 5778866A GB 1170790 A GB1170790 A GB 1170790A
Authority
GB
United Kingdom
Prior art keywords
chloro
sulphamyl
methylaniline
alkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB57788/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Filter Wallace and Tiernan Inc
Original Assignee
Wallace and Tiernan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallace and Tiernan Inc filed Critical Wallace and Tiernan Inc
Publication of GB1170790A publication Critical patent/GB1170790A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB57788/66A 1966-01-03 1966-12-23 Tetrahydro-Halo-Sulphamyl-Quinazolinones Expired GB1170790A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US517995A US3360518A (en) 1966-01-03 1966-01-03 Tetrahydro-halo-sulfamyl quinazolinones

Publications (1)

Publication Number Publication Date
GB1170790A true GB1170790A (en) 1969-11-19

Family

ID=24062092

Family Applications (1)

Application Number Title Priority Date Filing Date
GB57788/66A Expired GB1170790A (en) 1966-01-03 1966-12-23 Tetrahydro-Halo-Sulphamyl-Quinazolinones

Country Status (14)

Country Link
US (1) US3360518A (US20100056889A1-20100304-C00004.png)
AT (2) AT286989B (US20100056889A1-20100304-C00004.png)
BE (1) BE692082A (US20100056889A1-20100304-C00004.png)
BR (1) BR6785894D0 (US20100056889A1-20100304-C00004.png)
CH (1) CH515910A (US20100056889A1-20100304-C00004.png)
DE (1) DE1620740C3 (US20100056889A1-20100304-C00004.png)
DK (1) DK134113B (US20100056889A1-20100304-C00004.png)
ES (1) ES334560A1 (US20100056889A1-20100304-C00004.png)
FI (1) FI51350C (US20100056889A1-20100304-C00004.png)
FR (1) FR6844M (US20100056889A1-20100304-C00004.png)
GB (1) GB1170790A (US20100056889A1-20100304-C00004.png)
IL (1) IL27126A (US20100056889A1-20100304-C00004.png)
NL (1) NL149493B (US20100056889A1-20100304-C00004.png)
SE (1) SE390969B (US20100056889A1-20100304-C00004.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458513A (en) * 1967-11-02 1969-07-29 Wallace & Tiernan Inc 2-substituted-tetrahydro-halosulfamyl-quinazolinones
US3452020A (en) * 1967-11-09 1969-06-24 Wallace & Tiernan Inc 2-alkenyl and 2-alkynyl substituted - tetrahydro - halo-sulfamyl-quinazolinones
US3452019A (en) * 1967-11-16 1969-06-24 Wallace & Tiernan Inc 1-phenylalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3518267A (en) * 1968-02-23 1970-06-30 Pennwalt Corp 1-aminoalkyl and 1-hydroxyalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3549629A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2 - substituted or unsubstituted carboxy tetrahydro - halo - sulfamyl-quinazolinones
US3549636A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2-alkanoyl,alkanoylalkyl,alkanoyloxyalkyl,and hydroxyalkyl substituted tetrahydro - halo - sulfamyl- quinazolinones
US3549634A (en) * 1968-03-28 1970-12-22 Pennwalt Corp 8,5 - amino - substituted - tetrahydrohalo-sulfamyl-quinazolinones
US3541096A (en) * 1968-12-24 1970-11-17 Pennwalt Corp 2-aryl-substituted-tetrahydro-halo-sulfamyl-quinazolinones
ZA732937B (en) * 1972-05-05 1974-03-27 Maggioni & C Spa Non mercurial diuretics
EP0057763A1 (en) * 1981-01-26 1982-08-18 Pennwalt Corporation Improved process for the preparation of 2-methyl-3-(o-tolyl)-7-chloro-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide
US4522818A (en) * 1982-10-14 1985-06-11 Pennwalt Corporation Diuretic/antihypertensive compositions
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5264439A (en) * 1990-02-13 1993-11-23 Merck & Co., Inc. Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element
US5633240A (en) * 1994-09-01 1997-05-27 Academic Pharmaceuticals Parenteral solutions containing metolazone
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
AU1432402A (en) * 2000-11-21 2002-06-03 Sankyo Co Medicinal compositions
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
WO2006055542A2 (en) * 2004-11-15 2006-05-26 Nitromed, Inc. Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
EP3025711B1 (en) 2013-07-23 2020-11-18 Daiichi Sankyo Company, Limited Medicine for preventing or treating hypertension
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EA202191892A1 (ru) 2019-01-18 2022-02-24 Астразенека Аб Ингибиторы pcsk9 и способы их применения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976289A (en) * 1961-03-21 X-tetrahydro -
GB1464445A (en) * 1973-02-19 1977-02-16 Mitsubishi Electric Corp Apparatus for making a printing master
EP0096084B1 (de) * 1982-06-04 1985-10-02 DR.-ING. RUDOLF HELL GmbH Verfahren zur Vermeidung von Bildfehlern beim Mehrfarbendruck, die durch fehlerhaften Übereinanderdruck der Farbauszüge entstehen
GB8410860D0 (en) * 1984-04-27 1984-06-06 Crosfield Electronics Ltd Image modification

Also Published As

Publication number Publication date
CH515910A (de) 1971-11-30
DK134113C (US20100056889A1-20100304-C00004.png) 1977-02-14
IL27126A (en) 1972-01-27
NL6700083A (US20100056889A1-20100304-C00004.png) 1967-07-04
SE390969B (sv) 1977-01-31
DE1620740A1 (de) 1970-05-21
AT291269B (de) 1971-07-12
DK134113B (da) 1976-09-13
BE692082A (US20100056889A1-20100304-C00004.png) 1967-06-16
NL149493B (nl) 1976-05-17
DE1620740C3 (de) 1979-05-10
BR6785894D0 (pt) 1973-12-27
ES334560A1 (es) 1967-11-01
FI51350B (US20100056889A1-20100304-C00004.png) 1976-08-31
US3360518A (en) 1967-12-26
AT286989B (de) 1971-01-11
DE1620740B2 (de) 1978-09-14
FR6844M (US20100056889A1-20100304-C00004.png) 1969-04-08
FI51350C (fi) 1976-12-10

Similar Documents

Publication Publication Date Title
GB1170790A (en) Tetrahydro-Halo-Sulphamyl-Quinazolinones
GB1228606A (US20100056889A1-20100304-C00004.png)
GB1467927A (en) Derivatives of tyrosine having a pharmaceutical activity on smooth muscles
GB1503675A (en) Compositions based on pyrimidine derivatives and their use in the treatment of viral infections
GB1465661A (en) Stilbene derivatives
GB1192768A (en) N-Substituted 2,3,4,5,-Tetrahydro-1H-3-Benzazepines
GB1478587A (en) Preparation of alpha-6-deoxy-5-hydroxytetracycline
GB1459506A (en) Piperidine derivatives
GB1377596A (en) Process for the preparation of 1-substituted 3-hydroxypyrazoles
GB1335363A (en) Substituted benzamidoacetohydroxamic acids
GB1131164A (en) Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them
GB1051686A (US20100056889A1-20100304-C00004.png)
SE7407493L (US20100056889A1-20100304-C00004.png)
GB1155512A (en) Novel 4-Oxa-Steroids
GB1310382A (en) Process for the preparation of glucofuranosides
GB1464227A (en) S-inosylcysteine and a process for producing the same
GB1200892A (en) Production of 2-aminomethyl-2,3-dihydrobenzofurans
GB1432379A (en) Preparation of quinoline derivatives
GB1231804A (US20100056889A1-20100304-C00004.png)
GB1460457A (en) Process for preparation of quinoline derivatives
GB1153809A (en) Benzdiaz[1,4]Epine Derivatives
GB1467348A (en) Polymerization of olefins and catalyst therefor
GB1182557A (en) Alkoxycarbonylamino Propanes and Process for Preparing Them
GB1207048A (en) Novel 2-alkyl-4-oxa-steroids and a process for the manufacture thereof
GB1461456A (en) 1-acetoxy-2-2-acetoxyethyl-cyclopent-1-ene